Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasbir Seehra

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Biorxiv : the Preprint Server for Biology|November 19, 2025
ACE-031, a Soluble Activin Type IIB Receptor, Increases Muscle Mass and Strength in the Common Marmoset (Callithrix jacchus)Samuel M Cadena, Sasha Bogdanovich, Tejvir S Khurana, et al.
Plos One|February 13, 2026
ACE-031, a soluble activin type IIB receptor, increases muscle mass and strength in the common marmoset (Callithrix jacchus)Samuel M Cadena, Sasha Bogdanovich, Tejvir S Khurana, et al.
Bone|January 19, 2010
A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeysSutada Lotinun, R Scott Pearsall, Monique V Davies, et al.
Molecular Cancer Therapeutics|February 4, 2010
ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growthDianne Mitchell, Eileen G Pobre, Aaron W Mulivor, et al.
Endocrinology|May 3, 2012
A novel therapeutic approach to treating obesity through modulation of TGFβ signalingAlan Koncarevic, Shingo Kajimura, Milton Cornwall-Brady, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2008
A soluble activin type IIA receptor induces bone formation and improves skeletal integrityR Scott Pearsall, Ernesto Canalis, Milton Cornwall-Brady, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 10, 2010
Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivoAndrew D Chantry, Debby Heath, Aaron W Mulivor, et al.
Bone|September 29, 2009
Treatment with a soluble receptor for activin improves bone mass and structure in the axial and appendicular skeleton of female cynomolgus macaques (Macaca fascicularis)Roberto José Fajardo, Rajaram K Manoharan, R Scott Pearsall, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2012
A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strengthMarc Baud'huin, Nicolas Solban, Milton Cornwall-Brady, et al.
American Journal of Hematology|January 10, 2025
A Recombinant Antibody Against ALK2 Promotes Tissue Iron Redistribution and Contributes to Anemia Resolution in a Mouse Model of Anemia of InflammationChia-Yu Wang, Emiliano Melgar-Bermudez, Diana Welch, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|November 19, 2025
ACE-031, a Soluble Activin Type IIB Receptor, Increases Muscle Mass and Strength in the Common Marmoset (Callithrix jacchus)Samuel M Cadena, Sasha Bogdanovich, Tejvir S Khurana, et al.
Plos One|February 13, 2026
ACE-031, a soluble activin type IIB receptor, increases muscle mass and strength in the common marmoset (Callithrix jacchus)Samuel M Cadena, Sasha Bogdanovich, Tejvir S Khurana, et al.
Bone|January 19, 2010
A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeysSutada Lotinun, R Scott Pearsall, Monique V Davies, et al.
Molecular Cancer Therapeutics|February 4, 2010
ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growthDianne Mitchell, Eileen G Pobre, Aaron W Mulivor, et al.
Endocrinology|May 3, 2012
A novel therapeutic approach to treating obesity through modulation of TGFβ signalingAlan Koncarevic, Shingo Kajimura, Milton Cornwall-Brady, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2008
A soluble activin type IIA receptor induces bone formation and improves skeletal integrityR Scott Pearsall, Ernesto Canalis, Milton Cornwall-Brady, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 10, 2010
Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivoAndrew D Chantry, Debby Heath, Aaron W Mulivor, et al.
Bone|September 29, 2009
Treatment with a soluble receptor for activin improves bone mass and structure in the axial and appendicular skeleton of female cynomolgus macaques (Macaca fascicularis)Roberto José Fajardo, Rajaram K Manoharan, R Scott Pearsall, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2012
A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strengthMarc Baud'huin, Nicolas Solban, Milton Cornwall-Brady, et al.
American Journal of Hematology|January 10, 2025
A Recombinant Antibody Against ALK2 Promotes Tissue Iron Redistribution and Contributes to Anemia Resolution in a Mouse Model of Anemia of InflammationChia-Yu Wang, Emiliano Melgar-Bermudez, Diana Welch, et al.
Pageof 3